Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Quick Hits: SEC Inspects Apple


Brief scrutiny of today's headlines.

It's not nice to fib, especially about issues that might hammer a company's stock price.

The US Securities and Exchange Commission is reviewing Apple's (AAPL) disclosures about CEO Steve Jobs' health to be sure stockholders weren't mislead.

Bloomberg News, citing an unnamed tipster, reports that the SEC's review "doesn't mean investigators have seen evidence of wrongdoing."

The charismatic and notoriously cranky Jobs is considering a liver transplant following complications from cancer treatment. He was diagnosed with pancreatic cancer in 2004 and appeared unusually thin at recent public appearances.

Initially, Jobs said he sought treatment for a "relatively simple" nutritional ailment and he would remain at the helm of the company he co-founded. But 9 days later, Jobs said his health problems were "more complex" and he would take a medical leave of absence.

Apple's stock rose about 4.2% on January 5 when Job said he suffered from a hormone imbalance. The shares have lost about 8.4% since January 14 when the company said the 53-year-old Jobs would be out through June.

File this one under: Stupid things smart people do.

No one can blame Jobs for wanting to keep his health problems private, but he's smart enough to realize that what happens to him affects Apple - or at least he should be able to figure that out. It's possible, however, that Jobs didn't know how severely his condition had deteriorated.

In 2006, Jobs caused a flap with back-dated stock options. The US Department of Justice investigated, but no charges were filed. Nevertheless, the continuing soap opera tarnished Apple.

Everyone wishes Jobs well and wants him back at Apple doing what he doest best - creating zippy, innovative, "must-have" products. Let's hope that one of these days Jobs will realize he has responsibilities to others - including all those pesky stockholders who adore him.
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos